reports
- ABGSC Chemicals Research
- Bengt Jonassen
- Martin Melbye
X-PITCH 2023 Announces Global TOP100 Startups
EQS Newswire / 16/03/2025 / 14:15 CET/CEST Accelerating DeeptechSINGAPORE - - 3 October 2023 - X-PITCH is delighted to introduce 2023 TOP100 startups. Chosen from a pool of over 3,000 startups around the world, this year's selection showcases a diverse and vibrant ecosystem of entrepreneurial talent. X-PITCH 2023 is driven by a shared commitment to accelerate deeptech innovation across four vital domains: Healthcare, Advanced Manufacturing, Sustainability, and Digital Economy. The statistics speak to the global reach and diversity of the competition. Among the semi-finalists, 88% origin...
- ABGSC Energy Research
- Haakon Amundsen
- John Olaisen
- Njål Kleiven
- Oliver Dunvold
- Stian Wibstad
iolite a convoqué une assemblée extraordinaire de Dynacor Group Inc. -...
FREIENBACH, Suisse--(BUSINESS WIRE)-- iolite Capital Management AG, un gestionnaire d’investissement basé en Suisse (« iolite »), en tant que représentant d'iolite Partners Ltd., détenteur d’au moins 10 % des actions avec droit de vote émises et en circulation de Dynacor Group Inc. (TSX : DNG, la « société »), annonce la tenue de l'assemblée extraordinaire des actionnaires de la société (l'« assemblée ») le 16 avril 2025, au lieu du 9 avril 2025. En outre, iolite a fixé la date d'enregistrement au 14 mars 2025 (la « date d'enregistrement »). Comme le Conseil actuel n'a pas convoqué une réunio...
Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRαM...
Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRαME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025 - The late-breaking oral presentation at SGO 2025 highlights consistent response rates observed in patients across all levels of FRα expression of 25% or greater - SOUTH SAN FRANCISCO, Calif., March 15, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced expanded data in a late-breaking oral presentatio...
- VRS RESEARCH TEAM
Valuing Software Startups in Europe and North America: Tips & Takeaway...
We highlight some tips and takeaways from VRS Team’s engagement in valuation assignments with regard to SaaS startup companies in Europe and North America.
- VRS RESEARCH TEAM
UNITED KINGDOM Macro Note & Financial Model, December 2024
The UK economy has recently shown signs of stabilizing after a period of stagnation, with a modest uptick in household spending and business investment.
- VRS RESEARCH TEAM
- VRS RESEARCH TEAM
Dry Bulk Shipping Market | Quick Note by VRS Team – December 2024
BDI at the Lows of Year 2024 Trading Range
- Gary Brode
Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society...
Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients with platinum-resistant ovarian cancer (PROC) and continues to demonstrate an objective response rate (ORR) of ~35% in response-evaluable patients On track to initiate Part 2 of the ongoing DENALI clinical trial in 1H 2025, with registration-intent topline data anticipated by year end 2026 Company also presents preclinical com...
Krona Public Real Estate AB: 1 director
A director at Krona Public Real Estate AB bought 62,963 shares at 54.380SEK and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
Puma SE: 1 director
A director at Puma SE bought 10,000 shares at 21.850EUR and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showi...
Sunview Group Berhad: 1 director
A director at Sunview Group Berhad bought 2,530,000 shares at 0.395MYR and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
Coveo Solutions Inc: 1 director
A director at Coveo Solutions Inc bought 20,000 shares at 0.000CAD and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
A & W Food Services of Canada Inc: 1 director
A director at A & W Food Services of Canada Inc maiden bought 9,644 shares at 33.006CAD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over ...
Franco-Nevada Corporation: 6 directors
Six Directors at Franco-Nevada Corporation sold after exercising options/sold 21,700 shares at between 209.758CAD and 217.081CAD. The significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trade...
Baytex Energy Corp: 1 director
A director at Baytex Energy Corp sold 175,000 shares at 2.836CAD and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
Guangzhou Sanfu Newmaterials Technology Co Ltd : 3 directors
A director at Guangzhou Sanfu Newmaterials Technology Co Ltd sold after exercising options/sold 196,000 shares at 54.810CNY and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades...
National Bank Of Canada: 1 director
A director at National Bank Of Canada bought 2,147 shares at 116.280CAD and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.